McGeorge Anne is a director of The Oncology Institute, Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Dianthus Therapeutics, Inc. /DE/
28 May 24
4
Oncology Institute, Inc.
28 Dec 23
4
Dianthus Therapeutics, Inc. /DE/
13 Sep 23
4
Oncology Institute, Inc.
21 Mar 23
4
Oncology Institute, Inc.
21 Nov 22
4
Magenta Therapeutics, Inc.
30 Jun 22
4
SOC Telemed, Inc.
7 Apr 22
4
Oncology Institute, Inc.
23 Mar 22
3
Oncology Institute, Inc.
16 Nov 21
4
SOC Telemed, Inc.
7 Jun 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 May 24 | DNTH Dianthus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 21.77 | 11,000 | 239.47 k | 11,000 |
| 26 Dec 23 | TOI The Oncology Institute, Inc. | Common stock | Grant | Acquire A | No | No | 0 | 56,000 | 0.00 | 127,346 |
| 11 Sep 23 | DNTH Dianthus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.2 | 6,500 | 72.80 k | 6,500 |